Development and validation of a method for profiling post-translational modification activities using protein microarrays.

Article Details


Del Rincon SV, Rogers J, Widschwendter M, Sun D, Sieburg HB, Spruck C

Development and validation of a method for profiling post-translational modification activities using protein microarrays.

PLoS One. 2010 Jun 28;5(6):e11332. doi: 10.1371/journal.pone.0011332.

PubMed ID
20596523 [ View in PubMed

BACKGROUND: Post-translational modifications (PTMs) impact on the stability, cellular location, and function of a protein thereby achieving a greater functional diversity of the proteome. To fully appreciate how PTMs modulate signaling networks, proteome-wide studies are necessary. However, the evaluation of PTMs on a proteome-wide scale has proven to be technically difficult. To facilitate these analyses we have developed a protein microarray-based assay that is capable of profiling PTM activities in complex biological mixtures such as whole-cell extracts and pathological specimens. METHODOLOGY/PRINCIPAL FINDINGS: In our assay, protein microarrays serve as a substrate platform for in vitro enzymatic reactions in which a recombinant ligase, or extracts prepared from whole cells or a pathological specimen is overlaid. The reactions include labeled modifiers (e.g., ubiquitin, SUMO1, or NEDD8), ATP regenerating system, and other required components (depending on the assay) that support the conjugation of the modifier. In this report, we apply this methodology to profile three molecularly complex PTMs (ubiquitylation, SUMOylation, and NEDDylation) using purified ligase enzymes and extracts prepared from cultured cell lines and pathological specimens. We further validate this approach by confirming the in vivo modification of several novel PTM substrates identified by our assay. CONCLUSIONS/SIGNIFICANCE: This methodology offers several advantages over currently used PTM detection methods including ease of use, rapidity, scale, and sample source diversity. Furthermore, by allowing for the intrinsic enzymatic activities of cell populations or pathological states to be directly compared, this methodology could have widespread applications for the study of PTMs in human diseases and has the potential to be directly applied to most, if not all, basic PTM research.

DrugBank Data that Cites this Article

NameUniProt ID
Beta-adrenergic receptor kinase 2P35626Details
Activin receptor type-1BP36896Details
Insulin-like growth factor 1 receptorP08069Details
Tyrosine-protein kinase ITK/TSKQ08881Details
Kinesin-like protein KIF2CQ99661Details
Protein kinase C gamma typeP05129Details
Ephrin type-A receptor 1P21709Details
Muscle, skeletal receptor tyrosine-protein kinaseO15146Details
Serine/threonine-protein kinase PAK 3O75914Details